2024
The cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early estrogen receptor-positive breast cancer: a systematic review (Journal article)
Gue, Y., Lau, D., Lip, G., Shantsila, A., & Palmieri, C. (n.d.). The cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early estrogen receptor-positive breast cancer: a systematic review. Archives of Medical Science. doi:10.5114/aoms/190743DOI: 10.5114/aoms/190743
Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis. (Journal article)
Bucci, T., Gue, Y., Dobson, R., Palmieri, C., Pignatelli, P., & Lip, G. Y. H. (2024). Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis.. Clinical and experimental medicine, 24(1), 124. doi:10.1007/s10238-024-01395-zDOI: 10.1007/s10238-024-01395-z
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort. (Journal article)
Chen, Y., Gue, Y., Banach, M., Mikhailidis, D., Toth, P. P., Gierlotka, M., . . . LIPIDOGRAM Investigators. (2024). Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort.. European journal of clinical investigation, e14261. doi:10.1111/eci.14261DOI: 10.1111/eci.14261
Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke. (Journal article)
Chen, Y., Gue, Y., McDowell, G., Gorog, D. A., & Lip, G. Y. H. (2024). Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke.. Minerva medica, 115(3), 364-379. doi:10.23736/s0026-4806.24.09133-xDOI: 10.23736/s0026-4806.24.09133-x
Suh, J. -W., Memtsas, V., Gue, Y. X., Cho, H. -W., Lee, W., Kang, S. -H., & Gorog, D. A. (2024). Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects.. Thrombosis and haemostasis, 124(6), 501-516. doi:10.1055/s-0043-1777794DOI: 10.1055/s-0043-1777794
Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines. (Journal article)
Cheang, I., Zhu, X., Huang, J. -Y., Tse, Y. -K., Li, H. -L., Ren, Q. -W., . . . Yiu, K. -H. (2024). Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines.. Cancer. doi:10.1002/cncr.35322DOI: 10.1002/cncr.35322
Gue, Y., Bloomfield, D., Freedholm, D., & Lip, G. Y. H. (2024). Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.. Journal of clinical medicine, 13(8), 2277. doi:10.3390/jcm13082277DOI: 10.3390/jcm13082277
Gue, Y. X., Memtsas, V., Kanji, R., Wellsted, D. M., Busby, A., Smith, M., . . . Gorog, D. A. (2024). Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study.. Thrombosis research, 236, 144-154. doi:10.1016/j.thromres.2024.02.030DOI: 10.1016/j.thromres.2024.02.030
The Reply. (Journal article)
Gue, Y., & Lip, G. Y. H. (2024). The Reply.. The American journal of medicine, 137(3), e61. doi:10.1016/j.amjmed.2023.11.024DOI: 10.1016/j.amjmed.2023.11.024
Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate? (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2024). Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?. The American journal of cardiology, 213, 182-183. doi:10.1016/j.amjcard.2023.12.039DOI: 10.1016/j.amjcard.2023.12.039
Chen, Y., Gue, Y., Calvert, P., Gupta, D., McDowell, G., Azariah, J. L., . . . KERALA-AF Registry & APHRS-AF Registry Investigators joint senior authors. (2024). Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.. Current problems in cardiology, 49(4), 102456. doi:10.1016/j.cpcardiol.2024.102456DOI: 10.1016/j.cpcardiol.2024.102456
One‐year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala‐AF Registry (Journal article)
Calvert, P., Chen, Y., Gue, Y., Gupta, D., Azariah, J. L., George Koshy, A., . . . Gopalan, B. C. (n.d.). One‐year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala‐AF Registry. Journal of Arrhythmia. doi:10.1002/joa3.13059DOI: 10.1002/joa3.13059
2023
Increased risk of venous thromboembolism in patients with gastrointestinal disorders (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2023). Increased risk of venous thromboembolism in patients with gastrointestinal disorders. AMERICAN JOURNAL OF HEMATOLOGY. doi:10.1002/ajh.27140DOI: 10.1002/ajh.27140
Gue, Y. X., & Lip, G. Y. H. (2023). Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?. Cell reports. Medicine, 4(11), 101284. doi:10.1016/j.xcrm.2023.101284DOI: 10.1016/j.xcrm.2023.101284
Point-of-care biomarkers of thrombotic status predict spontaneous reperfusion in ST-segment elevation MI and clinical outcomes (Journal article)
Kanji, R., Gue, Y. X., Memtsas, V., Spencer, N. H., & Gorog, D. A. (2023). Point-of-care biomarkers of thrombotic status predict spontaneous reperfusion in ST-segment elevation MI and clinical outcomes. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.1373DOI: 10.1093/eurheartj/ehad655.1373
Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis (Journal article)
Bucci, T., Gue, Y., Dobson, R., Palmieri, C., Pignatelli, P., Cross, M., & Lip, G. Y. H. (2023). Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.2876DOI: 10.1093/eurheartj/ehad655.2876
Thrombotic profile of East Asian and Western ACS patients and relationship to cardiovascular outcomes (Journal article)
Suh, J. W., Memstas, V., Gue, Y. X., Cho, H. Y., Lee, W., Kang, S. H., & Gorog, D. A. (2023). Thrombotic profile of East Asian and Western ACS patients and relationship to cardiovascular outcomes. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.1368DOI: 10.1093/eurheartj/ehad655.1368
Gue, Y., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (2023). Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.. The American journal of medicine, 136(11), 1099-1108.e2. doi:10.1016/j.amjmed.2023.07.019DOI: 10.1016/j.amjmed.2023.07.019
Hypertension and atrial fibrillation: Closing a virtuous circle (Chapter)
Gue, Y. X., & Lip, G. Y. H. (2023). Hypertension and atrial fibrillation: Closing a virtuous circle. In Advances in Surgical and Medical Specialties (pp. 191-195).
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (Journal article)
Kanji, R., Gue, Y. X., Memtsas, V., Spencer, N. H., & Gorog, D. A. (2023). Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 81(19), 1918-1932. doi:10.1016/j.jacc.2023.03.388DOI: 10.1016/j.jacc.2023.03.388
Meta-analysis Comparing long-term clinical outcomes of percutaneous coronary intervention versus no intervention in patients with chronic total occlusion (Journal article)
Ibrahem, A., Farag, M., Gue, Y. X., Spinthakis, N., Al-Atta, A., & Egred, M. (2023). Meta-analysis Comparing long-term clinical outcomes of percutaneous coronary intervention versus no intervention in patients with chronic total occlusion. HEART VIEWS, 24(2), 104-108. doi:10.4103/heartviews.heartviews_82_22DOI: 10.4103/heartviews.heartviews_82_22
Farag, M., Peverelli, M., Spinthakis, N., Gue, Y. X., Egred, M., & Gorog, D. A. (2023). Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction-Prevalence, Importance and Approaches to Management. CARDIOVASCULAR DRUGS AND THERAPY, 37(1), 169-180. doi:10.1007/s10557-021-07226-7DOI: 10.1007/s10557-021-07226-7
2022
Harrison, S. L., Buckley, B. J. R., Zheng, Y., Hill, A., Hlaing, T., Davies, R., . . . Jones, I. (2022). Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study. American Heart Journal. doi:10.1016/j.ahj.2022.12.004DOI: 10.1016/j.ahj.2022.12.004
MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint) (Journal article)
Gue, Y. X., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (n.d.). MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint). JMIR AI. doi:10.2196/43822DOI: 10.2196/43822
MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint) (Preprint)
DOI: 10.2196/preprints.43822
Kanji, R., Gue, Y. X., Farag, M. F., Spencer, N. H., Mutch, N. J., & Gorog, D. A. (2022). Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. JACC-BASIC TO TRANSLATIONAL SCIENCE, 7(11), 1069-1082. doi:10.1016/j.jacbts.2022.05.007DOI: 10.1016/j.jacbts.2022.05.007
Stroke prevention in atrial fibrillation (Journal article)
Lip, G. Y. H., Gue, Y., Zhang, J., Chao, T. -F., Calkins, H., & Potpara, T. (2022). Stroke prevention in atrial fibrillation. TRENDS IN CARDIOVASCULAR MEDICINE, 32(8), 501-510. doi:10.1016/j.tcm.2021.10.001DOI: 10.1016/j.tcm.2021.10.001
Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction (Conference Paper)
Kanji, R., Gue, Y. X., Farag, M. F., Mutch, N. J., & Gorog, D. A. (2022). Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac157.034DOI: 10.1093/cvr/cvac157.034
Cardiovascular and metabolic effects of ovarian suppression as adjuvant therapy for early breast cancer: a systematic review and meta-analysis (Conference Paper)
Gue, Y. (2022). Cardiovascular and metabolic effects of ovarian suppression as adjuvant therapy for early breast cancer: a systematic review and meta-analysis. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac157.021DOI: 10.1093/cvr/cvac157.021
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? (Journal article)
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?. CIRCULATION, 146(16), 1207-1209. doi:10.1161/CIRCULATIONAHA.122.061987DOI: 10.1161/CIRCULATIONAHA.122.061987
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper (Journal article)
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. THROMBOSIS AND HAEMOSTASIS, 122(10), 1625-1652. doi:10.1055/s-0042-1750385DOI: 10.1055/s-0042-1750385
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More? (Journal article)
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?. JAMA CARDIOLOGY, 7(8), 794-795. doi:10.1001/jamacardio.2022.1572DOI: 10.1001/jamacardio.2022.1572
Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications (Journal article)
Nelson, J. A., Gue, Y. X., Christensen, J. M., Lip, G. Y. H., & Ramakrishna, H. (2022). Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 36(7), 2177-2195. doi:10.1053/j.jvca.2021.05.011DOI: 10.1053/j.jvca.2021.05.011
A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R (Conference Paper)
Gue, Y. X., Kanji, R., Wellsted, D., Srinivasan, M., Wyatt, S., & Gorog, D. (2022). A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.215DOI: 10.1093/cvr/cvac066.215
Diurnal Variation in thrombolytic status in patients presenting with STEMI (Conference Paper)
Gue, Y. X., Farag, M., Spinthakis, N., Wellsted, D., & Gorog, D. (2022). Diurnal Variation in thrombolytic status in patients presenting with STEMI. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.050DOI: 10.1093/cvr/cvac066.050
Diurnal variation in thrombotic and fibrinolytic status in healthy volunteers (Journal article)
Gue, Y., Memtsas, V., Kanji, R., & Gorog, D. (2022). Diurnal variation in thrombotic and fibrinolytic status in healthy volunteers. Cardiovascular Research, 118(Supplement_1). doi:10.1093/cvr/cvac066.217DOI: 10.1093/cvr/cvac066.217
Does targeted temperature management increase the risk of stent thrombosis in survivors of out-of-hospital cardiac arrest? A single centre experience (Conference Paper)
Kanji, R., Gue, Y. X., Saw, A. M., Shahid, M. Q., & Gorog, D. A. (2022). Does targeted temperature management increase the risk of stent thrombosis in survivors of out-of-hospital cardiac arrest? A single centre experience. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.218DOI: 10.1093/cvr/cvac066.218
Relationship between coronary stenosis severity and high shear thrombosis assessment in vitro (Conference Paper)
Gue, Y. X., Spinthakis, N., Topping, W., Patel, J., Baydoun, A., Farrington, K., . . . Gorog, D. (2022). Relationship between coronary stenosis severity and high shear thrombosis assessment in vitro. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.216DOI: 10.1093/cvr/cvac066.216
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2022). Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(6). doi:10.1111/eci.13754DOI: 10.1111/eci.13754
LONG TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION: A META-ANALYSIS OF RANDOMISED TRIALS (Conference Paper)
Ibrahem, A., Farag, M., Gue, Y. X., Spinthakis, N., Al-Atta, A., & Egred, M. (2022). LONG TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION: A META-ANALYSIS OF RANDOMISED TRIALS. In HEART Vol. 108 (pp. A36-A38). doi:10.1136/heartjnl-2022-BCS.51DOI: 10.1136/heartjnl-2022-BCS.51
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. (Journal article)
Piccini, J. P., Caso, V., Connolly, S. J., Fox, K. A. A., Oldgren, J., Jones, W. S., . . . PACIFIC-AF Investigators. (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.. Lancet (London, England), 399(10333), 1383-1390. doi:10.1016/s0140-6736(22)00456-1DOI: 10.1016/s0140-6736(22)00456-1
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EUROPACE. doi:10.1093/europace/euac020DOI: 10.1093/europace/euac020
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., . . . Proietti, M. (2022). Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. THROMBOSIS AND HAEMOSTASIS, 122(03), 406-414. doi:10.1055/a-1515-9630DOI: 10.1055/a-1515-9630
Diurnal and weekly variation in thrombotic and fibrinolytic status in healthy individuals (Conference Paper)
Memtsas, V. P., Gue, Y. X., Kanji, R., & Gorog, D. A. (2022). Diurnal and weekly variation in thrombotic and fibrinolytic status in healthy individuals. In CARDIOVASCULAR RESEARCH Vol. 118. Retrieved from https://www.webofscience.com/
META-ANALYSIS COMPARING LONG-TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION (Conference Paper)
Ibrahem, A., Farag, M., Gue, Y. X., Spinthakis, N., Al-Atta, A., Elzein, H., & Egred, M. (2022). META-ANALYSIS COMPARING LONG-TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 79 (pp. 846). Retrieved from https://www.webofscience.com/
2021
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2021). Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 8(12). doi:10.3390/jcdd8120177DOI: 10.3390/jcdd8120177
Crizanlizumab A CRITICAL Drug During a CRITICAL Time? (Journal article)
Gue, Y. X., Pula, G., & Lip, G. Y. H. (2021). Crizanlizumab A CRITICAL Drug During a CRITICAL Time?. JACC-BASIC TO TRANSLATIONAL SCIENCE, 6(12), 946-947. doi:10.1016/j.jacbts.2021.10.013DOI: 10.1016/j.jacbts.2021.10.013
Gue, Y. X., El-Bouri, W. K., & Lip, G. Y. H. (2021). Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.. European heart journal. Digital health, 2(3), 361-362. doi:10.1093/ehjdh/ztab068DOI: 10.1093/ehjdh/ztab068
Myslivecek, L., Gue, Y., & Vasiliadis, I. (2021). Case report of subacute presentation of tricuspid valve thrombus complicated by widespread bilateral pulmonary emboli: a multifactorial aetiology. EUROPEAN HEART JOURNAL-CASE REPORTS, 5(8). doi:10.1093/ehjcr/ytab282DOI: 10.1093/ehjcr/ytab282
Myocardial Ischaemia And Angina In Men (Chapter)
Gorog, D. A., & Gue, Y. X. (2021). Myocardial Ischaemia And Angina In Men. In Men's Health (pp. 166-173). CRC Press. doi:10.1201/9780429347238-20DOI: 10.1201/9780429347238-20
El-Bouri, W. K., Gue, Y., & Lip, G. Y. H. (2021). 'Rise of the machines': the next frontier in individualized medicine.. Cardiovascular research. doi:10.1093/cvr/cvab220DOI: 10.1093/cvr/cvab220
Hypertension and atrial fibrillation: Closing a virtuous circle (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2021). Hypertension and atrial fibrillation: Closing a virtuous circle. PLOS MEDICINE, 18(6). doi:10.1371/journal.pmed.1003598DOI: 10.1371/journal.pmed.1003598
Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon? (Journal article)
Kotalczyk, A., Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2021). Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?. EXPERT OPINION ON PHARMACOTHERAPY, 22(8), 1061-1070. doi:10.1080/14656566.2021.1879050DOI: 10.1080/14656566.2021.1879050
The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients (Journal article)
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., . . . Proietti, M. (2021). The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.290DOI: 10.1093/europace/euab116.290
Kanji, R., Gue, Y. X., Memtsas, V., & Gorog, D. A. (2021). Fibrinolysis in Platelet Thrombi. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(10). doi:10.3390/ijms22105135DOI: 10.3390/ijms22105135
Gue, Y. X., Ding, W. Y., Lip, G. Y. H., & Gorog, D. A. (2021). Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out?. SN APPLIED SCIENCES, 3(5). doi:10.1007/s42452-021-04517-4DOI: 10.1007/s42452-021-04517-4
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 (vol 10, 21379, 2020) (Journal article)
Gue, Y. X., Tennyson, M., Gao, J., Ren, S., Kanji, R., & Gorog, D. A. (2021). Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 (vol 10, 21379, 2020). SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-87439-wDOI: 10.1038/s41598-021-87439-w
In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2021). In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events. ANNALS OF INTERNAL MEDICINE, 174(4), JC43. doi:10.7326/ACPJ202104200-043DOI: 10.7326/ACPJ202104200-043
GUE, Y. X., ADATIA, K., KANJI, R., POTPARA, T., LIP, G. Y. H., & GOROG, D. A. (2021). Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival. AMERICAN HEART JOURNAL, 234, 31-41. doi:10.1016/j.ahj.2020.12.011DOI: 10.1016/j.ahj.2020.12.011
Jenner, W. J., Kanji, R., Mirsadraee, S., Gue, Y. X., Price, S., Prasad, S., & Gorog, D. A. (2021). Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 51(3), 595-607. doi:10.1007/s11239-021-02394-7DOI: 10.1007/s11239-021-02394-7
Gue, Y. X., Spinthakis, N., Egred, M., Gorog, D. A., & Farag, M. (2021). Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis. AMERICAN JOURNAL OF CARDIOLOGY, 142, 147-151. doi:10.1016/j.amjcard.2020.12.014DOI: 10.1016/j.amjcard.2020.12.014
Gue, Y. X., Jeong, Y. -H., Farag, M., Spinthakis, N., & Gorog, D. A. (2021). Precision Treatment in ACS-Role of Assessing Fibrinolysis. JOURNAL OF CLINICAL MEDICINE, 10(5). doi:10.3390/jcm10050929DOI: 10.3390/jcm10050929
Meta-analysis Comparing Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Grafting (Journal article)
Farag, M., Gue, Y. X., Brilakis, E. S., & Egred, M. (2021). Meta-analysis Comparing Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Grafting. AMERICAN JOURNAL OF CARDIOLOGY, 140, 47-54. doi:10.1016/j.amjcard.2020.10.062DOI: 10.1016/j.amjcard.2020.10.062
2020
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 (Journal article)
Gue, Y. X., Tennyson, M., Gao, J., Ren, S., Kanji, R., & Gorog, D. A. (2020). Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-78505-wDOI: 10.1038/s41598-020-78505-w
Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways (Journal article)
Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2020). Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways. CEREBROVASCULAR DISEASES, 49(6), 656-658. doi:10.1159/000512205DOI: 10.1159/000512205
Assessment of endogenous fibrinolysis using a point-of-care assay to identify increased cardiovascular risk in patients with diabetes and ACS (Conference Paper)
Kanji, R., Gue, Y. X., Dinarvand, D., Farag, M. Q., & Gorog, D. A. (2020). Assessment of endogenous fibrinolysis using a point-of-care assay to identify increased cardiovascular risk in patients with diabetes and ACS. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 1540). Retrieved from https://www.webofscience.com/
Correlation between plasma clot properties, thrombin generation and whole blood fibrinolytic assays in patients presenting with STEMI (Journal article)
Gue, Y., Mutch, N., Kanji, R., Farag, M., & Gorog, D. A. (2020). Correlation between plasma clot properties, thrombin generation and whole blood fibrinolytic assays in patients presenting with STEMI. European Heart Journal, 41(Supplement_2). doi:10.1093/ehjci/ehaa946.1551DOI: 10.1093/ehjci/ehaa946.1551
No difference in thrombotic profile of patients with ACS with obstructive CAD and MINOCA (Conference Paper)
Kanji, R., Gue, Y. X., Dinarvand, D., & Gorog, D. A. (2020). No difference in thrombotic profile of patients with ACS with obstructive CAD and MINOCA. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 1541). Retrieved from https://www.webofscience.com/
Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest (Journal article)
Gue, Y. X., Sayers, M., Whitby, B. T., Kanji, R., Adatia, K., Smith, R., . . . Gorog, D. A. (2020). Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 133(11), 1328-1335. doi:10.1016/j.amjmed.2020.03.046DOI: 10.1016/j.amjmed.2020.03.046
TCT CONNECT-251 Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis (Journal article)
Gue, Y., Brilakis, E., Egred, M., & Farag, M. (2020). TCT CONNECT-251 Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology, 76(17), B111. doi:10.1016/j.jacc.2020.09.268DOI: 10.1016/j.jacc.2020.09.268
Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19 (Journal article)
Gue, Y. X., Kanji, R., Markides, V., & Gorog, D. A. (2020). Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19. AMERICAN JOURNAL OF CARDIOLOGY, 130, 161-162. doi:10.1016/j.amjcard.2020.06.002DOI: 10.1016/j.amjcard.2020.06.002
Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19 (Journal article)
Gue, Y. X., & Gorog, D. A. (2020). Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19. EUROPEAN HEART JOURNAL, 41(33), 3198-3199. doi:10.1093/eurheartj/ehaa534DOI: 10.1093/eurheartj/ehaa534
Thrombosis Risk with Transcatheter Aortic Valve Replacement (Journal article)
Kanji, R., Mirsadraee, S., Prasad, S., Gue, Y. X., Panoulas, V., & Gorog, D. A. (2020). Thrombosis Risk with Transcatheter Aortic Valve Replacement. STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 4(5), 349-359. doi:10.1080/24748706.2020.1797256DOI: 10.1080/24748706.2020.1797256
Menahalli Palleda, G., Gupta, M. D., & Batra, V. (2020). Insights from multimodality imaging in a case of giant true coronary aneurysm treated percutaneously with polytetrafluoroethylene covered stent.. European heart journal. Case reports, 4(4), 1-2. doi:10.1093/ehjcr/ytaa123DOI: 10.1093/ehjcr/ytaa123
CLINICAL CODING ERRORS IN ELECTIVE DEVICE IMPLANTATION COSTING (Conference Paper)
Kiberu, Y., Ara, F., Gue, Y. X., & Szygula, J. (2020). CLINICAL CODING ERRORS IN ELECTIVE DEVICE IMPLANTATION COSTING. In HEART Vol. 106 (pp. A58-A59). doi:10.1136/heartjnl-2020-BCS.77DOI: 10.1136/heartjnl-2020-BCS.77
Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis (Journal article)
Gue, Y. X., Spinthakis, N., Farag, M., Kubica, J., Siller-Matula, J. M., Srinivasan, M., & Gorog, D. A. (2020). Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis. CLINICAL PHARMACOLOGY & THERAPEUTICS, 108(1), 54-62. doi:10.1002/cpt.1798DOI: 10.1002/cpt.1798
Myocardial infarction with non-obstructive coronary arteries in young women presenting with ST-segment elevation myocardial infarction: a case series (Journal article)
Kanji, R., Dinarvand, D., Gue, Y. X., & Gorog, D. A. (n.d.). Myocardial infarction with non-obstructive coronary arteries in young women presenting with ST-segment elevation myocardial infarction: a case series. Medical Research Journal. doi:10.5603/mrj.a2020.0006DOI: 10.5603/mrj.a2020.0006
Fatal heart block fromintentional yew tree (<i>Taxus baccata</i>) ingestion: a case report (Journal article)
Natasha, G., Chan, M., Gue, Y. X., & Gorog, D. A. (2020). Fatal heart block fromintentional yew tree (<i>Taxus baccata</i>) ingestion: a case report. EUROPEAN HEART JOURNAL-CASE REPORTS, 4(1). doi:10.1093/ehjcr/ytz226DOI: 10.1093/ehjcr/ytz226
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome (Journal article)
Gue, Y. X., Kanji, R., Wellsted, D. M., Srinivasan, M., Wyatt, S., & Gorog, D. A. (2020). Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 49(2), 192-198. doi:10.1007/s11239-019-02014-5DOI: 10.1007/s11239-019-02014-5
MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment (Journal article)
Gue, Y. X., Kanji, R., Gati, S., & Gorog, D. A. (2020). MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment. EUROPEAN CARDIOLOGY REVIEW, 15, 109-116. doi:10.15420/ecr.2019.13DOI: 10.15420/ecr.2019.13
Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis (Conference Paper)
Gue, Y., Brilakis, E., Egred, M., & Farag, M. (2020). Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 76 (pp. B111). Retrieved from https://www.webofscience.com/
2019
Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation (Journal article)
Gue, Y. X., Inoue, N., Spinthakis, N., Takei, A., Takahara, H., Otsui, K., . . . Gorog, D. A. (2019). Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(22), 2822-2824. doi:10.1016/j.jacc.2019.01.079DOI: 10.1016/j.jacc.2019.01.079
MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort (Journal article)
Gue, Y. X., Corballis, N., Ryding, A., Kaski, J. C., & Gorog, D. A. (2019). MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 48(4), 533-538. doi:10.1007/s11239-019-01919-5DOI: 10.1007/s11239-019-01919-5
Hausenloy, D. J., Kharbanda, R. K., Møller, U. K., Ramlall, M., Aarøe, J., Butler, R., . . . CONDI-2/ERIC-PPCI Investigators. (2019). Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.. Lancet (London, England), 394(10207), 1415-1424. doi:10.1016/s0140-6736(19)32039-2DOI: 10.1016/s0140-6736(19)32039-2
P327Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (Journal article)
Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). P327Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. European Heart Journal, 40(Supplement_1). doi:10.1093/eurheartj/ehz747.0162DOI: 10.1093/eurheartj/ehz747.0162
P4744Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis (Journal article)
Gue, Y. X., Spinthakis, N., Markides, V., Wong, T., & Gorog, D. (2019). P4744Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis. European Heart Journal, 40(Supplement_1). doi:10.1093/eurheartj/ehz745.1120DOI: 10.1093/eurheartj/ehz745.1120
Spinthakis, N., Gue, Y., Farag, M., Srinivasan, M., Wellsted, D., Arachchillage, D. R. J., . . . Gorog, D. A. (2019). Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation. EUROPACE, 21(9), 1297-1306. doi:10.1093/europace/euz176DOI: 10.1093/europace/euz176
A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome (Journal article)
Gue, Y. X., Prasad, S., Isenberg, D., & Gorog, D. A. (2019). A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome. EUROPEAN HEART JOURNAL-CASE REPORTS, 3(2). doi:10.1093/ehjcr/ytz041DOI: 10.1093/ehjcr/ytz041
155 Relationship between pre-procedural platelet reactivity and inflammatory markers to cardiac outcomes in patients undergoing PPCI (Conference Paper)
Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). 155 Relationship between pre-procedural platelet reactivity and inflammatory markers to cardiac outcomes in patients undergoing PPCI. In Acute Coronary Syndromes. BMJ Publishing Group Ltd and British Cardiovascular Society. doi:10.1136/heartjnl-2019-bcs.152DOI: 10.1136/heartjnl-2019-bcs.152
Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture (Journal article)
Spinthakis, N., Gue, Y., Farag, M., Ren, G., Srinivasan, M., Baydoun, A., & Gorog, D. A. (2019). Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 47(3), 392-395. doi:10.1007/s11239-018-01799-1DOI: 10.1007/s11239-018-01799-1
Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study (Journal article)
Farag, M., Spinthakis, N., Gue, Y. X., Srinivasan, M., Sullivan, K., Wellsted, D., & Gorog, D. A. (2019). Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. EUROPEAN HEART JOURNAL, 40(3), 295-305. doi:10.1093/eurheartj/ehy656DOI: 10.1093/eurheartj/ehy656
Effect of P2Y<sub>12</sub> inhibitors on thrombus stability and endogenous fibrinolysis (Journal article)
Spinthakis, N., Farag, M., Gue, Y. X., Srinivasan, M., Wellsted, D. M., & Gorog, D. A. (2019). Effect of P2Y<sub>12</sub> inhibitors on thrombus stability and endogenous fibrinolysis. THROMBOSIS RESEARCH, 173, 102-108. doi:10.1016/j.thromres.2018.11.023DOI: 10.1016/j.thromres.2018.11.023
Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis (Conference Paper)
Gue, Y. X., Spinthakis, N., Markides, V., Wong, T., & Gorog, D. (2019). Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 2948). Retrieved from https://www.webofscience.com/
Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (Conference Paper)
Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 125). Retrieved from https://www.webofscience.com/
Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction (Journal article)
Adatia, K., Farag, M. F., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction. THROMBOSIS AND HAEMOSTASIS, 119(11), 1785-1794. doi:10.1055/s-0039-1695007DOI: 10.1055/s-0039-1695007
2018
2151Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study (Journal article)
Farag, M., Spinthakis, N., Gue, Y., Srinivasan, M., Sullivan, K., Wellsted, D., & Gorog, D. A. (2018). 2151Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy565.2151DOI: 10.1093/eurheartj/ehy565.2151
P4651Incidence of MINOCA in patients presenting with STEMI for PPCI- applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort (Journal article)
Gue, Y. X., Farag, M., Spinthakis, N., Anwar, M., Gorog, D. A., & Srinivasan, M. (2018). P4651Incidence of MINOCA in patients presenting with STEMI for PPCI- applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy563.p4651DOI: 10.1093/eurheartj/ehy563.p4651
A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevationmyocardial infarction caused by a mediastinal mass (Journal article)
Gue, Y. X., Anwar, M., & Gorog, D. A. (2018). A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevationmyocardial infarction caused by a mediastinal mass. EUROPEAN HEART JOURNAL-CASE REPORTS, 2(1). doi:10.1093/ehjcr/yty008DOI: 10.1093/ehjcr/yty008
Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study (Conference Paper)
Farag, M., Spinthakis, N., Gue, Y., Srinivasan, M., Sullivan, K., Wellsted, D., & Gorog, D. A. (2018). Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 430-431). Retrieved from https://www.webofscience.com/
Incidence of MINOCA in patients presenting with STEMI for PPCI-applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort (Conference Paper)
Gue, Y. X., Farag, M., Spinthakis, N., Anwar, M., Gorog, D. A., & Srinivasan, M. (2018). Incidence of MINOCA in patients presenting with STEMI for PPCI-applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 960). Retrieved from https://www.webofscience.com/
2017
Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease (Journal article)
Spinthakis, N., Farag, M., Gorog, D. A., Prasad, A., Mahmood, H., Gue, Y., . . . Srinivasan, M. (2017). Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease. INTERNATIONAL JOURNAL OF CARDIOLOGY, 249, 101-106. doi:10.1016/j.ijcard.2017.09.156DOI: 10.1016/j.ijcard.2017.09.156
An uncommon manifestation of shock: Takotsubo syndrome (Journal article)
Gue, Y. X., Bhandari, S. S., & Ahamed, M. (2017). An uncommon manifestation of shock: Takotsubo syndrome. ECHO RESEARCH AND PRACTICE, 4(4), K41-K45. doi:10.1530/ERP-17-0040DOI: 10.1530/ERP-17-0040
An Unusual Case of Thromboembolic Stroke - Silent Myocardial Infarction from Spontaneous Coronary Artery Dissection (Journal article)
Gue, Y. X. (n.d.). An Unusual Case of Thromboembolic Stroke - Silent Myocardial Infarction from Spontaneous Coronary Artery Dissection. Angiology & Vascular Surgery, 2(1), 1-3. doi:10.24966/avs-7397/100006DOI: 10.24966/avs-7397/100006
Critical aortic stenosis presenting as STEMI (Journal article)
Gue, Y. X., Bhandari, S. S., & Kelly, D. J. (2017). Critical aortic stenosis presenting as STEMI. ECHO RESEARCH AND PRACTICE, 4(3), K7-K10. doi:10.1530/ERP-17-0017DOI: 10.1530/ERP-17-0017
Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation (Journal article)
Gue, Y. X., & Gorog, D. A. (2017). Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 18(9). doi:10.3390/ijms18091850DOI: 10.3390/ijms18091850
2014
Fosfomycin - is a second dose needed? (Conference Paper)
Gue, Y. X., & Kidder, D. (2014). Fosfomycin - is a second dose needed?. In SCOTTISH MEDICAL JOURNAL Vol. 59 (pp. E24-E25). Retrieved from https://www.webofscience.com/